marketcap
Facebook
Twitter
Telegram
Report an ErrorZIOPHARM Oncology, Inc. Financial Ratios 2011-2024 | ZIOP
Annual Financial Ratios ZIOPHARM Oncology, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-9.9 | -5.8 | -5.7 | -10.6 | -4.6 | -5.2 | -28.5 | -6.6 | -3.3 | -5.6 |
P/S |
- | - | 2064.2 | 90.0 | 110.2 | 143.9 | 659.2 | 469.5 | 392.7 | 537.3 |
EV/EBITDA |
-8.6 | -10.6 | -4.5 | -9.5 | -4.1 | -4.0 | -20.0 | -5.4 | -2.4 | -3.6 |
PEG |
-0.31 | 0.07 | -0.19 | -0.18 | 0.12 | 0.02 | -0.54 | -0.14 | 0.13 | 0.15 |
P/B |
6.4 | 7.2 | 3.5 | 12.2 | 15.7 | 7.1 | 26.7 | 7.6 | 6.5 | 5.0 |
P/CF |
-11.8 | -16.7 | -6.0 | -10.4 | -12.8 | -1477.1 | -24.6 | -6.3 | -3.9 | -9.0 |
ROE % |
-64.51 | -123.98 | -62.08 | -115.13 | -344.20 | -137.45 | -93.91 | -115.64 | -198.44 | -89.07 |
ROA % |
-54.65 | -107.96 | -55.88 | -51.44 | -155.43 | -78.12 | -70.25 | -79.59 | -115.26 | -58.99 |
ROCE % |
-62.79 | -59.90 | -63.00 | -63.12 | -182.58 | -88.57 | -126.41 | -90.23 | -158.30 | -75.36 |
DSO |
- | - | 4660.0 | 1.1 | 1.1 | 37.6 | 38.5 | 66.2 | 26.5 | 43.2 |
DIO |
- | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - |
All numbers in USD currency